KLOTHO Therapeutics Investor

Biotechnology companyВідповідно до джерел: 3KLOTHO Therapeutics (KTI™) is a biotechnology company developing a patent-pending Klotho protein that has great potential to redefine society’s experience with Therapeutics (KTI) is a biotechnology company developing a patent-pending Klotho protein that has great potential to delay diseases of aging and help people live well Therapeutics - Therapeutics is a biotechnology company developing modified recombinant versions of the human protein Klotho. It has potential to promote longevity and delay dementia, kidney disease, diabetes, and Therapeutics